Resources

To aid decision-makers interested in human papillomavirus (HPV) vaccine introduction or scale-up, in 2014–2016 the London School of Hygiene & Tropical Medicine and PATH conducted the first comprehensive review of HPV vaccine delivery experiences across 46 low- and middle-income countries.These experiences have helped countries learn valuable lessons about effective methods for garnering parental acceptance and reaching young adolescent girls with the vaccine, at relatively low delivery costs. The lessons learnt from these countries can provide critical information for policymakers and program planners on how best to prepare, deliver, and sustain HPV vaccines.Highlights include key findings and lessons from HPV vaccination experience across five themes: preparation, communications, delivery, achievements, and sustainability. Also addressed are the value of demonstration projects and potential HPV vaccination pitfalls.NOTE: In April 2025, the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium published updated briefs that summarize new evidence on preparations, communications, effective delivery, sustaining programs, and pitfalls. The HAPPI Consortium is managed by JSI together with its partners Clinton Health Access Initiative (CHAI), the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, Jhpiego, and PATH.

This publication describes PATH’s efforts to examine the use and acceptability of maternal influenza immunization in El Salvador. The qualitative study captures the perspectives of pregnant women, family decision makers, community leaders, public health practitioners, private physicians, and more. The report identifies both successful strategies as well as challenges to vaccine uptake, and offers recommendations for countries considering the introduction of maternal influenza immunization.

PATH’s Reach Campaign is raising $125 million by the close of 2017 to accelerate progress toward a world where health is within reach for everyone, no matter where they live. As detailed in this case for support, we are focusing on areas of greatest need and opportunity: malaria elimination, women’s and reproductive health, maternal and newborn health, and child health.

This two-page fact sheet describes PATH’s collaboration with community-based organizations in Mumbai to develop a Private Provider Interface Agency (PPIA), which is a comprehensive urban TB service delivery model. The PPIA is designed to increase access to TB services for urban populations at high risk by engaging private practitioners in TB care.

For nearly 40 years, PATH has teamed up with India’s leaders and communities to translate the nation’s vast resources into better health for its women, children, and communities. Now, we invite you to join our experts and partners to experience this work firsthand.